These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17128097)

  • 1. [Announcement of amyotrophic lateral sclerosis diagnosis].
    Couratier P; Desport JC; Torny F; Lacoste M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S108-4S112. PubMed ID: 17128097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How should the diagnosis of amyotrophic lateral sclerosis be announced?].
    Campana-Salort E
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S113-4S121. PubMed ID: 17128098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honesty and hope: announcement of diagnosis in ALS.
    Silani V; Borasio GD
    Neurology; 1999; 53(8 Suppl 5):S37-9; discussion S40-2. PubMed ID: 10560636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods of the announcement of amyotrophic lateral sclerosis diagnosis in familial forms].
    Corcia P
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S122-4S126. PubMed ID: 17128099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breaking bad news during the course of amyotrophic lateral sclerosis: how and when].
    Salachas F
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S127-4S129. PubMed ID: 17128100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the news in amyotrophic lateral sclerosis.
    Borasio GD; Sloan R; Pongratz DE
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S127-33. PubMed ID: 9851662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychological reactions to the announcement of a severe disease diagnosis: the amyotrophic lateral sclerosis example].
    Brocq H; Soriani MH; Desnuelle C
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S104-4S107. PubMed ID: 17128096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis.
    Blatzheim K
    J Bodyw Mov Ther; 2009 Oct; 13(4):328-35. PubMed ID: 19761955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the benefits of currently available treatments justify early diagnosis and announcement? Arguments for.
    Cashman NR
    Neurology; 1999; 53(8 Suppl 5):S50-2; discussion S55-7. PubMed ID: 10560639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.
    Andersen PM; Borasio GD; Dengler R; Hardiman O; Kollewe K; Leigh PN; Pradat PF; Silani V; Tomik B;
    Amyotroph Lateral Scler; 2007 Aug; 8(4):195-213. PubMed ID: 17653917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Caring for a patient with amyotrophic lateral sclerosis: the patient's and the caregiver's experience].
    Fussellier M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S209-4S214. PubMed ID: 17128113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the news: a survey of ALS patients and their caregivers.
    McCluskey L; Casarett D; Siderowf A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):131-5. PubMed ID: 15512900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of health volunteers for patients with amyotrophic lateral sclerosis and their family].
    Bardet L
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S284-4S290. PubMed ID: 17128127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic Lateral Sclerosis: ethical issues from diagnosis to end of life.
    McCluskey L
    NeuroRehabilitation; 2007; 22(6):463-72. PubMed ID: 18198432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
    Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
    Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Issues of France's "Leonetti Act": Involvement of amyotrophic lateral sclerosis patients in prior discussions concerning respiratory support and end-of-life care].
    Danel-Brunaud V; Laurier L; Parent K; Moreau C; Defebvre L; Jacquemin D; Destée A
    Rev Neurol (Paris); 2009 Feb; 165(2):170-7. PubMed ID: 18937955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic variation in ALS].
    Sasaki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):825-7. PubMed ID: 17432191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.